Startups

Matic: $30 Million Raised For Advancing Embedded Insurance Technology Expansion

By Amit Chowdhry ● Jan 16, 2025

Leading insurance technology platform Matic Insurance Services announced it has secured $30 million from Vistara Growth, a provider of flexible growth capital to software and technology enabled services companies. And Matic offers an embedded insurance platform to mortgage servicers, originators, banks and other financial institutions to seamlessly offer home, auto, and other personal lines products to their customers.

Neumirna Therapeutics: €20 Million (Series A) Raised To Develop RNA Therapies For Neurological Disorders

By Amit Chowdhry ● Jan 16, 2025

Neumirna Therapeutics - an RNA-focused biotech company developing next-generation therapeutics for neurological disorders - announced the first closing of its Series A funding round at €20 million. New investors Angelini Ventures and Invivo Partners co-led the funding, with significant participation from Neumirna’s seed investor, Innovestor’s Life Science Fund, and other investors.

Coave Therapeutics: €32 Million (Series A) Raised For Advancing Genetic Medicines

By Amit Chowdhry ● Jan 16, 2025

Coave Therapeutics - a company advancing the future of genetic medicines - announced the raising of €32 million ($33 million) in Series A funding. The funding was co-led by Novo Holdings A/S and Bpifrance, with Invus and UI Investissement participation alongside existing investors Seroba Life Sciences, Fund+, Kurma Partners, Omnes Capital, and Turenne Capital.

Deep Vector: $1.5 Million (Seed) Raised For Transforming Insurance Data Extraction

By Amit Chowdhry ● Jan 16, 2025

Deep Vector, an AI-based platform for analyzing underwriting documents, announced it closed a seed round of $1.5 million, co-led by Aperture Venture Capital and InsurTech NY. And Deep Vector helps insurers and brokers translate the influx of analog documents used for underwriting risk: claims loss runs, Acord forms, motor vehicle records, and business records into usable and actionable data.

PrettyDamnQuick: $25 Million (Series A) Closed For Operational Data Platform

By Amit Chowdhry ● Jan 16, 2025

PrettyDamnQuick (PDQ), an operational data platform for profitable commerce, announced that it closed a $25 million Series A funding round led by Peakspan Capital, with participation from existing investors TLV Partners and Moneta. And PDQ will utilize the funds to expand its market presence and accelerate the development of its cutting-edge checkout and shipping personalization engine, which helps mid-sized Direct-to-Consumer (D2C) e-commerce brands to boost revenue and compete more effectively with massive global entities like Amazon. So far, PDQ has raised $38 million.

Abstract: $4.8 Million (Seed) Raised For Regulatory Risk Management Platform

By Amit Chowdhry ● Jan 16, 2025

Abstract, an artificial intelligence company developing the first regulatory superintelligence platform, announced it raised $4.8 million in seed funding co-led by Bonfire Ventures and Communitas Capital. This latest funding round brings Abstract’s total funding to over $9 million.

Qventus: $105 Million (Series D) For AI-Based Health System Automation

By Amit Chowdhry ● Jan 16, 2025

Qventus, a provider of AI-based care automation software for health systems, announced a $105 million investment led by KKR, with additional participation from renowned investment firm Bessemer Venture Partners, and new strategic investors, including leading health systems Northwestern Medicine, HonorHealth, and Allina Health. And this funding follows a year of significant growth for Qventus, increasing its cadre of health system partners and expanding its team globally.

Labviva: $25 Million (Series B) Raised For Accelerating Life Sciences Product Development

By Amit Chowdhry ● Jan 16, 2025

Labviva, a leading AI procurement platform for life sciences, announced the closing of its $25 million Series B, bringing the total funding to $55 million. The round was led by 53 Stations, with continued participation from Biospring Partners, B Capital Group, and Glasswing Ventures. And the funding reflects the company’s boom growth and escalating demand in Biopharma for automated supply chain and procurement solutions. In connection with the funding round, 53 Station’s co-founder and Managing Partner, Jason Pritzker, will join Labviva’s Board of Directors.

Clear Labs: $30 Million (Series D) Secured For Advancing Development Of Sequencing Solutions

By Amit Chowdhry ● Jan 16, 2025

Clear Labs, a provider of fully automated and next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it has raised $30 million in its Series D financing. This funding round was led by a strategic investor, along with participation from existing investors, including Counterpoint Global (Morgan Stanley), Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile Group, Wing Venture Capital, and funds and accounts advised by T. Rowe Price Associates.

Red Sky Health: $3 Million (Seed) Closed For Optimizing Healthcare Claims Management

By Amit Chowdhry ● Jan 16, 2025

Red Sky Health (RSH), an AI-based platform designed to optimize healthcare claims management, announced it has raised $3 million in seed funding. The funding round was led by serial entrepreneur and investor Trevor Burgess, along with notable alumni from Charles River Data, Gleb Drobkov, and Mike Dezube, now key figures in Neptune Flood's data science leadership.

Colossal: $200 Million (Series C) Raised At $10.2 Billion Valuation For De-Extinction Technology

By Amit Chowdhry ● Jan 16, 2025

De-extinction company Colossal Biosciences announced $200 million in a Series C funding round by TWG Global, jointly led by Mark Walter and Thomas Tull. And Colossal’s additional strategic investors include funds such as USIT, Animal Capital, Breyer Capital, At One Ventures, In-Q-Tel, BOLD Capital, Peak 6, and Draper Associates, and others and private investors including Robert Nelsen, Peter Jackson, Fran Walsh, Ric Edelman, Brandon Fugal, Paul Tudor Jones, Richard Garriott, Giammaria Giuliani, Sven-Olof Lindblad, Victor Vescovo, and Jeff Wilke.

Ubiety Technologies: $10 Million (Series A-1) Secured At $90 Million Valuation For Home Insights Platform

By Amit Chowdhry ● Jan 16, 2025

Ubiety Technologies announced that it has completed a $10 million Series A-1 financing. This funding will be used to enhance its product, accelerate the development of its proprietary AI engine, and expand go-to-market capabilities to meet the needs of its rapidly growing customer base.

Esphera SynBio: $2 Million (Seed) Funding Raised For Developing Nanomedicine Vaccines

By Amit Chowdhry ● Jan 16, 2025

Synthetic biology company Esphera SynBio announced the closing of a $2 million seed financing round. The funding builds on the company's advanced R&D activities and proceeds are directed at identifying an initial cancer vaccine clinical candidate and general corporate purposes. And seed investors GKCC and FACIT supported the financing.

Twentyeight Health: $10 Million (Series A) Secured To Advance Women’s Healthcare Platform

By Amit Chowdhry ● Jan 16, 2025

Twentyeight Health, a leading digital-first women's healthcare platform delivering convenient, affordable, and stigma-free reproductive and sexual care in 43 states, announced $10 million in Series A funding led by Seae Ventures, with participation from Impact America Fund, The Social Entrepreneurs' Fund, RH Capital, Impact Engine, Gratitude Railroad, and Townhall Ventures. And this brings the company's total funding to $25 million.

Jotit: Education Technology Company Raises $10 Million (Seed)

By Amit Chowdhry ● Jan 14, 2025

Jotit, a platform designed to simplify and streamline learning in the digital age, announced the closing of its $10 million seed funding round led by Owl Ventures. Other key investors include Good Company VC, Cresson Management, Two Lanterns VC, One Line VC, Paul Volosov, Guy Gamzu, Amit Gilon, and MindCET Capital.

Aerin Medical: $32.5 Million Raised To Advance Growth

By Amit Chowdhry ● Jan 14, 2025

Aerin Medical - a high-growth medical device company focused on expanding access to meaningful relief for millions of patients suffering from chronic ENT conditions - announced the completion of two significant financial transactions.

Pipe17: AI-Based Order Operations Solutions Company Raises $15.5 Million (Series A)

By Amit Chowdhry ● Jan 14, 2025

Pipe17, a leading provider of AI-based composable order operations, announced a $15.5 million funding round, highlighting the company's rapid growth and strategic vision to transform commerce operations. And the company recently hired its first Chief Operating Officer, Kelly Goetsch, a recognized industry pioneer who joined Pipe17 from commercetools, where he helped scale the company to over $100 million in annual recurring revenue (ARR).

Float Financial: C$70 Million (Series B) Raised For Building Business Solutions

By Amit Chowdhry ● Jan 13, 2025

Float Financial, a business finance platform for Canadian businesses, has signed a C$70 million Series B financing round, bringing its total funds raised in the last year to $120 million. The funding round was led by Growth Equity at Goldman Sachs Alternatives, with participation from OMERS Ventures, FJ Labs, Teralys, and existing investor Garage Capital.

hc1: $6.25 Million Raised To Transform Lab Data Into Actionable Intelligence

By Amit Chowdhry ● Jan 13, 2025

hc1, a leader in transforming lab data into actionable intelligence that improves patient health outcomes while boosting the bottom line, announced it raised $6.25 million in new financing after a successful acquisition in October 2024 of Accumen. Existing investor Health Cloud Capital led the investment with participation from health tech investment firm A1 Health Ventures. And Arsenal Capital Partners joined the investor base in the combined platform via its ownership stake in Accumen.

ThreatMark: $23 Million Raised To Fight Online Fraud

By Amit Chowdhry ● Jan 13, 2025

ThreatMark, a leading innovator in behavior-based fraud prevention, announced it has closed a $23 million funding round. The funding round includes $15 million from Octopus Ventures and Riverside Acceleration Capital (RAC), a US-based growth capital partner to B2B software companies, and an $8 million convertible note from Springtide Ventures Fund.

Raspberry AI: Fashion-Focused GenAI Company Raises $24 Million (Series A)

By Amit Chowdhry ● Jan 13, 2025

Raspberry AI, a leading generative AI platform for fashion creatives, announced it secured $24 million in Series A funding led by Andreessen Horowitz (a16z). Existing investors Greycroft, Correlation Ventures, and MVP Ventures participated in the round, along with notable angel investors such as Gokul Rajaram and Ken Pilot.

BBT.live: Secure Connectivity Company Raises $11.5 Million (Seed)

By Amit Chowdhry ● Jan 13, 2025

BBT.live, an innovator in secure connectivity over public infrastructure, announced the expansion of its seed funding round to $11.5 million, driven by an additional $2 million investment. Accel Solutions Group led the funding round.

Kerna Labs: Seed Funding Raised To Develop Novel RNA-Based Medicines

By Amit Chowdhry ● Jan 13, 2025

Kerna Laboratories - a San Francisco-based AI biotech startup - announced it emerged from stealth with the launch of an AI platform for developing novel RNA-based medicines. Kerna Labs has recently closed an oversubscribed seed funding round, with investors including Gradient, Humba Ventures, Tau Ventures, Pioneer Fund, Focalpoint Partners, and prominent angels including Patrick Hsu (Arc Institute) and Jacob Kimmel (NewLimit).

First Ascent Biomedical: $6 Million Raised For Personalized Cancer Treatments

By Amit Chowdhry ● Jan 13, 2025

First Ascent Biomedical, a pioneer in personalized cancer treatment, announced a $6 million investment from Vidal Duart Enterprises, with an additional co-investment from Techstars. And the funding round will accelerate First Ascent Biomedical’s mission to transform medical oncology with highly individualized, prospective treatment planning technologies that improve patient survival.

Fermata: $10 Million (Series A) Raised For Computer Vision Agriculture Solutions

By Amit Chowdhry ● Jan 13, 2025

Fermata, a data science company specializing in computer vision agriculture solutions, announced it closed $10 million in a Series A funding round backed by Raw Ventures. This funding will support the company's vision of developing a centralized digital brain for the horticulture industry, enabling autonomous management of crops through advanced data analysis and creating a system that continuously learns from available data.

Caidya: Clinical Research Organization Raises $165 Million

By Amit Chowdhry ● Jan 13, 2025

Caidya, a leading global mid-sized clinical research organization (CRO), announced the closing of a strategic growth investment of $165 million from funds managed by Rubicon Founders, a U.S.-based healthcare investment firm focused on building transformational companies.

Windward Bio: Drug Development Company Raises $200 Million (Series A)

By Amit Chowdhry ● Jan 13, 2025

Novo Holdings, a leading life science investor, announced that it has invested in a $200 million Series A launch financing for Windward Bio. This oversubscribed Series A launch financing was co-led by OrbiMed, Novo Holdings and Blue Owl Healthcare Opportunities, and joined by SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital, and Pivotal bioVenture Partners.

RAAPID: Series A Funding Raised From Microsoft’s M12

By Amit Chowdhry ● Jan 13, 2025

Healthcare AI company RAAPID announced a significant Series A investment from M12, which is Microsoft's venture fund. And this strategic funding positions RAAPID to expand its groundbreaking Neuro-symbolic AI platform that reshapes healthcare risk adjustment.

Timberlyne: $180 Million (Series A) Raised To Develop Novel Therapies For Autoimmune Disorders

By Amit Chowdhry ● Jan 13, 2025

Timberlyne Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders, announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in-class monoclonal antibody targeting CD38, for diseases of high unmet medical needs. The funding was led by investors Abingworth, Bain Capital Life Sciences, and Venrock Healthcare Capital Partners, with participation from Boyu Capital, Lilly Asia Ventures, Braidwell LP, and 3H Health Investment.

nsave: $18 Million (Series A) Raised For Launching Investment Platform

By Amit Chowdhry ● Jan 13, 2025

nsave, a provider of compliant accounts abroad to people from countries with high inflation, announced launching an investment product, enabling people at risk of financial exclusion to protect and grow their wealth. The company also confirmed an $18 million Series A funding led by TQ Ventures with participation from Sequoia Capital, Y Combinator, ACE Ventures, and Proton Foundation to drive their growth.